Cardiol Therapeutics Files 6-K for April 2025 Shareholder Meeting
Ticker: CRDL · Form: 6-K · Filed: Apr 28, 2025 · CIK: 1702123
Sentiment: neutral
Topics: shareholder-meeting, agm, filing-update
Related Tickers: CRDL
TL;DR
Cardiol Therapeutics (CRDL) filed its April 6-K, including AGM docs. Shareholders, get ready to vote!
AI Summary
Cardiol Therapeutics Inc. filed a Form 6-K on April 28, 2025, for the month of April 2025. The filing includes several exhibits related to their Annual General Meeting of Shareholders, such as the Notice of Meeting, Management Information Circular, and Form of Proxy. The company is incorporated in Canada and its fiscal year ends on December 31.
Why It Matters
This filing provides shareholders with essential information and documents for the upcoming Annual General Meeting, allowing them to participate in corporate governance.
Risk Assessment
Risk Level: low — This filing is routine administrative and shareholder communication, not indicating new financial or operational risks.
Key Players & Entities
- Cardiol Therapeutics Inc. (company) — Registrant
- April 28, 2025 (date) — Filing date
- April 2025 (date) — Reporting period
- December 31 (date) — Fiscal year end
- 001-40712 (other) — Commission File Number
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is filed for the month of April 2025 and includes exhibits related to Cardiol Therapeutics Inc.'s Annual General Meeting of Shareholders.
What are the key exhibits included in this filing?
The key exhibits are: Notice of Annual General Meeting of Shareholders (Exhibit 99.1), Management Information Circular (Exhibit 99.2), Form of Proxy (Exhibit 99.3), and Notice of Availability of Proxy Materials (Exhibit 99.4).
When is Cardiol Therapeutics Inc.'s fiscal year end?
Cardiol Therapeutics Inc.'s fiscal year ends on December 31.
What is the company's principal executive office address?
The company's principal executive office is located at 602-2265 Upper Middle Road East, Oakville, Ontario, Canada L6H 0G5.
What is the Commission File Number for Cardiol Therapeutics Inc.?
The Commission File Number for Cardiol Therapeutics Inc. is 001-40712.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 28, 2025 regarding Cardiol Therapeutics Inc. (CRDL).